If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGI.L Regulatory News (SGI)

  • There is currently no data for SGI

Long Term Incentive Plan (LTIP) Awards

25 Sep 2008 15:22

RNS Number : 3421E
Stanley Gibbons Group Limited
25 September 2008
 



The Stanley Gibbons Group Limited

25 September 2008

The Stanley Gibbons Group Limited

('Stanley Gibbons' or 'the Company')

Long Term Incentive Plan (LTIP) Awards

The Company announces that on 19 September 2008 the following awards were made to Executive Directors under the Company's 2007 Long-Term Incentive Plan (LTIP). 

Michael Hall - Chief Executive 105,500

Mark Henley - Finance Director 46,500

Richard Purkis - Operations Director 46,500

The Options were granted for nil consideration. The Option granted to Michael Hall is exercisable at a price of £1.61 being the closing mid market price on the preceding business day, 18 September 2008. The Options granted to Mark Henley and Richard Purkis are exercisable at par value.

The Options will vest on 19 September 2011, subject to the satisfaction of the following performance conditions:

50% of an award: EPS

Performance Period

Vesting of this part of the award will be determined by the Company's adjusted EPS growth over three complete financial years (i.e. adjusted to allow for the impact of amortisation and non-recurring items). The base year for calculating growth from will be the financial year ending 31 December 2007.

Targets

From the base year, three-year earnings growth will need to be delivered as follows for vesting to take place:

Less than 35% above RPI: no vesting;

35% above RPI: 12.5% of the initial award (25% of the part of the award subject to EPS performance) vests;

75% above RPI: 50% of the initial award (100% of the part of the award subject to EPS performance) vests; and

Straight line vesting takes place between performance points.

50% of an award: TSR

Peer Group

Vesting of this part of the award will be determined by Company's TSR performance relative to the constituents of the FTSE Small Cap excluding investment trusts (the "comparator group"). 

Performance Period

The TSR performance period and comparator group will be set from the date of award for three years.

Targets

Vesting will take place as follows based on the Company's relative TSR performance against the comparator group:

Below median: no vesting;

median: 12.5% of the initial award (25% of the part of the award subject to TSR performance) vests;

Upper quartile: 50% of the initial award (100% of the part of the award subject to TSR performance) vests; and

Straight line vesting takes place between performance points.

To mitigate the impact of short-term movements in share price on the relative TSR condition, there will be a three month averaging of the base and end total return index values for each company.

For further information, contact:

The Stanley Gibbons Group Limited

Michael Hall, Chief Executive 01481 708270

Richard Purkis, Company Secretary 020 7836 8444

Seymour Pierce Limited

Jonathan Wright 020 7107 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMGGZLDKLGRZM
Date   Source Headline
1st Aug 20177:00 amRNSFurther Update on Disposal of Interiors Division
20th Jul 20172:19 pmRNSForm 8.3 - Stanley Gibbons Group Plc
14th Jul 20177:30 amRNSUpdate on Disposal of Interiors Division
13th Jul 20173:15 pmRNSForm 8.3 - Stanley Gibbons Group plc
30th Jun 20179:27 amRNSForm 8.3 - The Stanley Gibbons Group plc
28th Jun 20173:15 pmRNSForm 8.3 - Stanley Gibbons Group plc
27th Jun 20173:15 pmRNSForm 8.3 - Stanley Gibbons Group plc
26th Jun 20178:23 amRNSForm 8.3 - Stanley Gibbons Group Plc - Amendment
23rd Jun 201710:37 amRNSForm 8.3 - Stanley Gibbons Group PLC
22nd Jun 20171:36 pmRNSDavid Preston Mann - Form 8.3
22nd Jun 20171:26 pmRNSEvolution Securities China Form 8.3
22nd Jun 201711:56 amRNSEvolution Securities China Form 8.3
21st Jun 20177:00 amRNSForm 8.3 - Stanley Gibbons Group PLC
20th Jun 20173:15 pmRNSForm 8.3 - Stanley Gibbons Group plc
16th Jun 20173:36 pmRNSForm 8.3 - Stanley Gibbons Group Plc
16th Jun 20179:30 amRNSForm 8 (OPD) - The Stanley Gibbons Group Plc
15th Jun 201711:41 amRNSForm 8.3 Amendment - Stanley Gibbons Group Plc
15th Jun 201711:29 amRNSForm 8.3 - Stanley Gibbons Plc
15th Jun 201710:44 amRNSForm 8.3 - Stanley Gibbons Group plc
15th Jun 201710:42 amRNSForm 8.3 - Stanley Gibbons Group plc
14th Jun 20179:42 amRNSForm 8.3 - Stanley Gibbons Group Plc
13th Jun 20171:04 pmRNSForm 8.3 - Stanley Gibbons Group Plc
13th Jun 201711:35 amRNSUpdate
12th Jun 20174:28 pmRNSForm 8.3 - Stanley Gibbons Group Plc
12th Jun 201712:09 pmRNSForm 8.3 - Stanley Gibbons Group Plc
12th Jun 201711:51 amRNSForm 8.3 - The Stanley Gibbons Group plc
12th Jun 20177:00 amRNSStrategic Review and Formal Sales Process
12th Jun 20177:00 amRNSResponse to Stanley Gibbons Group PLC Statement
9th Jun 201711:35 amRNSForm 8 (DD) - Stanley Gibbons Group PLC
9th Jun 20179:13 amRNSStatement re Possible Offer
30th May 20177:00 amRNSSale of interest in Masterpiece London Ltd
16th May 201712:00 pmRNSBlock listing Interim Review
9th May 20177:00 amRNSDisposal of Interiors Division and Trading Update
19th Apr 20177:00 amRNSRare Indian stamps sold for record £500,000
4th Apr 201710:02 amRNSHolding(s) in Company
4th Apr 201710:00 amRNSHolding(s) in Company
1st Feb 201712:45 pmRNSResult of EGM
11th Jan 201712:25 pmRNSHolding(s) in Company
30th Dec 201611:15 amRNSInterim Results and Notice of EGM
1st Dec 20165:15 pmRNSChange of Registered Office
27th Oct 20161:35 pmRNSResult of AGM and Director Retirement
6th Oct 20167:00 amRNSGrant of Options
4th Oct 20167:00 amRNSBoard Appointment
3rd Oct 20167:03 amRNSFinal Results
15th Sep 20167:00 amRNSDirectorate Change
15th Jul 20167:00 amRNSCorporate Update, Board Changes and Audit Update
30th Jun 20162:49 pmRNSTiming of Results
24th May 20164:33 pmRNSHolding(s) in Company
24th May 20167:00 amRNSSale of Premises & Board Appointments
17th May 20167:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.